Weekly paclitaxel versus weekly docetaxel in elderly or frail patients with metastatic breast carcinoma: a randomized phase-II study of the Belgian Society of Medical Oncology.

Benoit Beuselinck,Hans Wildiers,Wim Wynendaele,Luc Dirix,Jean-Pierre Kains,Robert Paridaens

Critical Reviews in Oncology/Hematology（2010）

引用 23|浏览10

暂无评分

摘要

This randomized phase-II trial investigated the efficacy and tolerability of weekly docetaxel or paclitaxel in metastatic breast cancer (MBC) patients considered unfit for a 3-weekly therapy.

查看译文

关键词

Metastatic breast cancer,Taxanes,Frail and elderly patients

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要